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Nigella is a small genus of the family Ranunculaceae,which includes somepopular species due
to their culinary and medicinal properties, especially in Eastern Europe, Middle East, Western,
and Central Asia. Therefore, this review covers the traditional uses and phytochemical
composition of Nigella and, in particular, Nigella sativa. The pharmacological studies
reported in vitro, in vivo, and in humans have also been reviewed. One of the main
strength of the use of Nigella is that the seeds are rich in the omega-6 fatty acid linoleic
acid and provide an extra-source of dietary phytochemicals, including the bioactive
thymoquinone, and characteristics saponins, alkaloids, and flavonoids. Among Nigella
species, N. sativa L. is the most studied plant from the genus. Due to the phytochemical
composition and pharmacological properties, the seed and seed oil from this plant can be
considered as good candidates to formulate functional ingredients on the basis of folklore and
scientific knowledge. Nonetheless, the main limations are that more studies, especially, clinical
trials are required to standardize the results, e.g. to establish active molecules, dosage,
chemical profile, long-term effects and impact of cooking/incorporation into foods.
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INTRODUCTION
Nigella, also known as fennel flower, is a small genus belonging to
the family Ranunculaceae and includes around 20 species (Zohary,
1983; The plant list, 2020). The members of the genus are annuals
and survive harsh condition as seed (therophytes) with a short life
cycle (Agradi et al., 2002). A popular ornamental species, Nigella
damascena L. (commonly known as lady-in-a-mist or ragged lady),
and a well-known condiment and spice, Nigella sativa L. (also
known as black cumin or black seeds), have a high commercial
interest especially in the food, pharmaceutical and cosmetics
industries (Ali and Blunden, 2003; Bittkau and Comes, 2009;
Malhotra, 2012). As an example, N. sativa is used in foods,
pickles, and baked goods (Malhotra, 2012).
The evolutionary origins of Nigella species are presumably in
the Aegean and the adjacent Western-Irano-Turanian region; its
centre of species diversity (Zohary, 1983; Bittkau and Comes,
2009). The genus is found as wild in southern Europe, Russia,
northern Africa, Asia Minor, Turkey, Middle-East, India,
Pakistan, and Bangladesh (Tonçer and Kizil, 2004; Zohary,
1983; Dönmez and Mutlu, 2004; Heiss and Oeggl, 2005;
Sharma et al., 2009; Iqbal et al., 2010; Heiss et al., 2011;
Rabbani et al., 2011; Zhao et al., 2013; Hossan et al., 2018).
The taxonomic position of Nigella has undergone many
changes in the past few decades. It has been commonly
divided into three sections viz. Komaroffia, Garidella and
Nigella (Tutin et al., 1972; Tamura, 1993; Uğurlu Aydın and
Dönmez, 2019). Section Komaroffia comprises one species
(Nigella integrifolia Regel), section Garidella consists of two
species (Nigella nigellastrum (L.) Willk. and Nigella
unguicularis (Poir.) Spenn.), whereas section Nigella composed
of twelve species, including N. sativa, N. damascena and others
(Nigella arvensis L.,Nigella fumariifola Kotschy,Nigella hispanica
L., Nigella segetalis M. Bieb., Nigella stellaris Boiss., Nigella elata
Boiss., Nigella ciliaris DC., Nigella orientalis L., Nigella oxypetala
Boiss., and Nigella turcica Dönmez and Mutlu) (Zohary, 1983;
Heiss et al., 2011). In the Plant List, a working list of known plant
species produced by the botanical community, there are
91 Nigella names, but only 23 are accepted latin names for
species (The plant list, 2020). In general, this genus is
characterized by angular or discoid seeds and the
characteristic black color is related to other common name of
Nigella, “black cumin” (Zhao et al., 2013).
Due to their ethnopharmacology as healing herbs and food
importance of Nigella spp., the present work reviews their
traditional uses and phytochemical composition, as well as
various scientific studies related to their health benefit with
special emphasis in N. sativa.
TRADITIONAL USES OF NIGELLA
Latest ethno-pharmacological studies showed that Nigella species
are among the most usually used for traditional and folk
medicinal practices. Among them, N. sativa is probably the
best-known species of the Nigella genus and it has been used
in many parts of the world as a natural medicine. The traditional
use of N. sativa dates from the 1st century A.D.; Pliny the Elder
recommended N. sativa as a digestive and an ingredient of
antidotes curing snake bites and scorpion stings (Dönmez and
Mutlu, 2004), or even at least till Tutankhamen kingdom
(Mrozek-Wilczkiewicz et al., 2016). Today, the seed powder of
N. sativa is recommended at 0.5–4 g in the Pharmacopoeia of
India (Tajmiri et al., 2016), which is used as a stimulant to ease
bowel and indigestion problems and as carminative. It has also
been administered to manage pain during menstruation and
diabetes in India and Bangladesh (Esakkimuthu et al., 2016;
Hossan et al., 2018). Similarly, N. sativa is widely used in
traditional medicine of Algeria for the treatment of diabetes
and also to treat high blood pressure (BP) (Bouzabata, 2013).
Moreover, according to the Bedouins (Egypt), the wooden stem is
used to treat jaundice, while seeds are used to treat BP as before, as
well as heart diseases, etc. (El-Seedi et al., 2013) (Table 1). Similar
uses have been reported in Iranian traditional medicine (Ghazeeri
et al., 2012; Amiri and Joharchi, 2013; Bahmani et al., 2016b), in
Pakistan (Khan et al., 2014; Yaseen et al., 2015; Aziz et al., 2017) and
in Morocco (Eddouks et al., 2002; El-Hilaly et al., 2003; Khabbach
et al., 2012; Jamila and Mostafa, 2014; Teixidor-Toneu et al., 2016),
where N. sativa seeds and leaves are orally ingested, consumed as a
powder, herbal tea, as decoction or as inhalant. In Pakistan N. sativa
is also applied to manage lactation, bacterial diseases, etc. (Khan
et al., 2014; Aziz et al., 2017), while in Morocco the seeds are
recommended to deal with otolaryngological, urological, and
nephrological ailments as well as to treat pathologies of the
respiratory and skeleton–muscular systems, allergy and hyper-
sensibility (Eddouks et al., 2002; El-Seedi et al., 2013; Jamila and
Mostafa, 2014). The anti-rheumatic and analgesic properties of N.
sativa combined with honey have been reported (Khabbach et al.,
2012). In addition, seeds infusion is used to treat malaria in the
Malaysian traditional medicine (Al-Adhroey et al., 2010), as well as
seeds (fresh, dried, and powdered forms) and leaves in Ethiopia
(Alrawi et al., 2017). The use of N. sativa is still more widespread,
being recognized as panacea for its healing properties inQatar (Alrawi
et al., 2017) and Bangladesh (Jennings et al., 2015). Some of the latter
uses are also common in Mauritius, Nepal, Turkey, Thailand,
Lebanon, and Palestine (Ghazeeri et al., 2012; Al-Ramahi et al.,
2013; Sreekeesoon and Mahomoodally, 2014; Guler et al., 2015;
Jennings et al., 2015; Kunwar et al., 2015; Bahmani et al., 2016a;
Neamsuvan et al., 2016; Alrawi et al., 2017; Ahmed et al., 2018).
Furthermore, in Bangladesh and Libano N. sativa seeds are used as a
spice and food preservative, directly consumed after being ground,
while Nigella oil also can be applied topically (Jennings et al., 2015).
Similarly, seeds of N. sativa (also named Nigella glandulifera Freyn
and Sint.) are consumed in some regions of China and frequently
added to “naan” (a crusty pancake). Its water decoction is used in the
Uighur’s traditionalmedicine for the treatment of numerous disorders
as the other species (Table 1) (Zhao et al., 2013).
OtherNigella species with a wide range of medicinal properties
are N. damascena and N. ciliaris. In Central Europe, the use of N.
damascena dates from Bronze Age but it cannot reliably assign
any ethnobotanical relevance and its origin is unclear; it has never
grown in the wild in central Europe (Heiss and Oeggl, 2005).
Alternatively,N. damascena seeds are used for example in Sicilian
folk medicine as a galactogogue (Geraci et al., 2018). Other uses
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are as emmenagogue, vermifugue, and disinfectant (Heiss and
Oeggl, 2005). This plant is also used as an helmintic agent and to
treat hematuria, and skin diseases in the Serbian medieval
medicine (Jarić et al., 2014). The former use has also been
reported in Epirus (Greece) (Vokou et al., 1993). Traditionally,
N. damascena is used for treating trachoma in Tunisia and Italy
(Leporatti and Ghedira, 2009). Besides its use as herbal remedy,
N. damascena is used as a condiment in several regions (Heiss and
Oeggl, 2005), including in Morocco (Khabbach et al., 2011).
In the folklore medicine of Palestine and Iran,N. ciliaris seeds are
used for abdominal pain, to facilitate delivery and to treat menstrual
cycle related problems, respectively (Ali-Shtayeh et al., 2015)
(Bahmani et al., 2015). In Turkey, Meriç Town, dried flowers of
N. arvensis are used as a winter tea (Kartal and Güneş, 2017). On the
other hand, in Iran (Kerman), the seed powder ofN. arvensismixed
with other seeds are administrated to enhance male potency and to
improve memory and intelligence (Khajoei Nasab and Khosravi,
2014). The seeds of bothNigella species are used for the treatment of
cancer in Palestine (Jaradat et al., 2016a; Hamarsheh et al., 2017).
PHYTOCONSTITUENTS
Nigella genus is widely used for their culinary and medicinal
properties especially in the Eastern Europe, Middle East, Western
and Central Asia. The plants are mainly consumed for their seeds
and seed oil, as commented before. The main constituents of N.
sativa seeds reported in the literature are fixed oil (27–40%),
proteins (16–19%), characterized mainly by the amino acids
arginine, glutamic acid, leucine, lysine; minerals (1.79–3.74%),
like Cu, Zn, P, and Fe; carbohydrates (28.5–33.7%), and solubre
dietary fibers (5.5–8.9%) (Al-Naqeep et al., 2009; Tiruppur
Venkatachallam et al., 2010; Kooti et al., 2016; El-Naggar
et al., 2017; Saxena et al., 2017). Concerning the
phytochemical composition of Nigella seeds, the most
interesting plant part, it is constituted of alkaloids, terpenes
and phenolic compounds (Agradi et al., 2001). Although the
number of studies on the chemical composition and
pharmacological properties of N. sativa is continuously
increasing (Bourgou et al., 2010b), there are other interesting
species for their culinary andmedicinal properties, as commented
before. Thus, this section details phytochemicals found in N.
sativa and other Nigella plants.
Fixed Oil: Essential Fatty Acids
The oil of N. sativa seeds has been highly studied, showing
predominance of linoleic acid (1) (50–60%), oleic acid (2)
(20%), myristic acid (3) (30%), and palmitic acid (4) (12.5%)
(Tiruppur Venkatachallam et al., 2010; Kooti et al., 2016; El-
Naggar et al., 2017; Saxena et al., 2017) (Figure 1).Nigella seed oil
fromMorocco also showed that the major fatty acids were linoleic
acid (1) (58.5 and 56.5%), oleic acid (2) (23.8 and 24.9%) and
palmitic acid (4) (13.1 and 11.9%) using cold press and solvent
extraction, respectively (Gharby et al., 2015). The major
compounds were similar to those found in N. sativa seeds
from other Mediterranean countries. These fatty acids were
TABLE 1 | Some traditional uses of Nigella species.
Species Traditional use Country References
Asia
N. arvensis (seed) To treat lung, brain and skin Palestine (Jaradat et al., 2016a)
N. ciliaris (seed) To treat abdominal pain and to facilitate delivery Palestine (Ali-Shtayeh et al., 2015)
N. ciliaris (seed) To treat menstrual cycle problems Iran (Bahmani et al., 2015)
N. ciliaris (seed) To treat cancer Palestine ((Jaradat et al., 2016a; Hamarsheh et al., 2017)
N. sativa (seed) To treat diuretic, analgesic, insomnia, dizziness, tinnitus, amnesia, and
bronchial disorders
China (Zhao et al., 2013)
N. sativa (seed) To ease bowel and indigestion problems and to manage diabetes India (Tajmiri et al., 2016)
(Esakkimuthu et al., 2016)
N. sativa (seed) To manage pain during menstruation and diabetes Bangladesh (Esakkimuthu et al., 2016) (Esakkimuthu et al.,
2016) (Hossan et al., 2018
N. sativa (seed) Curative effects in bacterial-caused diseases, sexual tonic, to manage
lactation and to decrease mental disturbances
Pakistan (Khan et al., 2014; Aziz et al., 2017)
N. sativa (seed) To treat malaria Malaysia (Al-Adhroey et al., 2010)
Africa
N. sativa (seed) Hypoglycemic and hypotensive agent Algeria (Bouzabata, 2013)
N. sativa (wooden stem
and seed)
Wooden steem: To treat jaundice. Seeds: Hypotensive agent and to treat
heart diseases, headaches, nasal congestion, toothache, and against
intestinal worms
Egypt (El-Seedi et al., 2013)
N. sativa (seed, fruit and
leaf)
Hypoglycemic and hypotensive agent and to deal with digestive, respiratory,
and cardiovascular problems, and allergy
Morocco (Eddouks et al., 2002; El-Seedi et al., 2013;
Jamila and Mostafa, 2014)
Europe
N. damascena Galactagogue (seed) and against trachoma Italy (Geraci et al., 2018) (Leporatti and Ghedira, 2009)
N. damascena Antihelmintic (for children) and to treat haematuria and skin diseases
(itchiness and eczema)
Serbia (Geraci et al., 2018)
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also reported as major compounds from the seed oils, extracted
by n-hexane, of different N. sativa genotypes from India (Saxena
et al., 2017). Other study have shown that fixed oils fromN. sativa
seed from Turkey and Egypt obtained by supercritical CO2
extraction were similar in fatty acid composition of saturated
fatty acids (16%), mainly constituted by palmitic acid (4) and
stearic acid (5); monounsaturated acids (23%), mainly oleic acid
and cis-vaccenic acid (6), and polyunsaturated acids (58%),
mainly linoleic acid (1) and eicosadienoic acid (7) (Piras et al.,
2013) (Figure 1). In this work the ratio omega-6/omega-3 ranged
between 180 and 221 considering linoleic and alpha-
linolenic acid.
Other Nigella species, including N. damascena, N. orientalis,
N. arvensis, N. elata, N. nigellastrum, N. oxypetala, N. segetalis, N.
unguicularis, and N. lancifolia Hub.-Mor., also contain linoleic
acid (31.2–69.5%) and oleic acid (15.8–36.0%) as the major ones
(Kökdil et al., 2005; Matthaus and Özcan, 2011). The abundance
relevance of other fatty acids depends on the species.
Volatile Oil Phytochemicals
Volatile oils are derived from plant tissues and are characterized
to evaporate under room temperature and failure to saponify.
Concerning volatile oil (around 0.5–1.5%) of Nigella seeds, it
showed high abundance of thymoquinone (8), p-cymene (9) and
other phenolic derivatives, such as dithymoquinone (nigellone)
(10), thymohydroquinone (11), carvacrol (12), and thymol (13)
(Bourgou et al., 2010b; Tiruppur Venkatachallam et al., 2010;
Kooti et al., 2016; El-Naggar et al., 2017).
These compounds are considered Nigella active principles
(Mahmoudvand et al., 2014), but the composition may vary
depending on the chemotype and species, among other factors
(Edris, 2010; Zribi et al., 2014; Koshak et al., 2017; Saxena et al.,
2017). As an example, N. sativa volatile composition (seeds) presents
different chemotypes (Burits and Bucar, 2000; Islam et al., 2004):
thymoquinone (8) chemotype in Egypt and Turkey varieties
(77.2–86.2%) (Piras et al., 2013); trans-anethole (14) (38.3%)
chemotype in Iranian N. sativa essential oil (Nickavar et al.,
2003); p-cymene (9) (33%), and thymol (13) (26.8%) chemotype
in Moroccan species (Moretti et al., 2004). The volatile oils from N.
sativa seeds of Turkey and Egypt obtained by supercritical fractioned
extraction with CO2 also showed that thymoquinone was the major
constituent (77.2–86.2%) followed by p-cymene (9) (5.4–11.0%)
(Piras et al., 2013). An essential oil from Iranian N. sativa seeds
was rich in thymoquinone (42.4%), p-cymene (14.1%) and caravacrol
FIGURE 1 | Fatty acids in fixed oils from Nigella seeds.
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(10.3%) (Mahmoudvand et al., 2014). Figure 2 depicts the chemical
structure of these phytochemicals and Table 2 the content of the
major ones and the source.
The essential oil composition is highly variable and probably
more chemotypes exist. As an example, Jrah Harzallah et al.
(2011) identified eighty-four compounds in the essential oil
obtained by hydrodistillation of N. sativa seeds from Tunisia
and the major one was the monoterpenes p-cymene (9) (49.48%),
α-thujene (15) (18.93%), α-pinene (16) (5.44%), β-pinene (16)
(4.31%). Alternatively, the bioactive compound thymoquinone
represented only 0.79%. Similar results were found by Geng et al.
(2009); N. sativa seeds contained p-cymene (9) (33.75%) as the
major component using the hydrodestillation mode, with low
content of thymoquinone (8) (3.73%), while using supercritical
CO2 extraction the major one was linoleic acid (1). Another study
reported that N. sativa seeds from Tunisia and Morocco showed
again that p-cymene (9) occurred in a higher relative
concentration (60.5 and 56.7%, respectively) (Bourgou et al.,
2010b; Badri et al., 2018). Furthermore, the essential oil
extracted by hydrodistillation from Egyptian seeds showed the
major components were p-cymene (9) (33.0%) and
thymoquinone (8) (32.2%), followed by α-thujene (15) (13.0%)
and camphene (19) (2.9%) (Viuda-Martos et al., 2011). Rarely,
the composition of N. sativa seeds essential oil from Poland
showed that two other monoterpenoids were present: cis- and
trans-4-methoxythujane (18) (Wajs et al., 2008). Bourgou et al.
FIGURE 2 | Phytochemical components in essential oils from Nigella seeds.
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(2012) has identified also four terpenoids, trans/cis-sabinene
hydrate methyl ether (20), 1,2-epoxy-menth-4-ene (21), and
1,2-epoxy-menth-4(8)-ene (22), in Tunisian N. sativa essential
oil from seeds by nuclear magnetic resonance (Figure 2).
Nigella damascena seed oil was characterized by almost 100%
sesquiterpenes, of which β-elemene (17) (73.2%) was the most
representative one (Moretti et al., 2004; Geng et al., 2009). Edris
(2009) also remarked that this compound could be present even
up to 73.0% in the essential oils of in N. orientalis and N. arvensis.
Alternatively, N. arvensis could also contain other compounds in
major levels, e.g. a methylated derivative of carvacrol (19)
(26.4%), carvacrol methyl ether, followed by β-pinene
(16) (21.4%).
Alkaloids
The bio-potential of nitrogen-containing heterocycles has been
recently revised (Thakral and Singh, 2019). In plants, alkaloids
contain one or more nitrogen atoms and usually are situated in
some cyclic system. Similarly, these nitrogen-containing
heterocycles, such as isoquinoline alkaloids and their
N-oxides, can be a source of leads for drug discovery
(Dembitskya et al., 2015). This included compound such as
nigellimine (23) and nigellimine-N-oxide (24) from N. sativa
seeds. This species also contains other type of alkaloids such as
nigellicine (25), and nigellidine-4-O-sulfite (26) (Figure 3).
Nigellidine (27) and its derivative methyl nigellidine,
higenamine (28), and nigeglanine (29) were also
characterized in N. sativa seeds (Atta Ur et al., 1995; Yun
et al., 2014). Among them, methyl nigellidine, nigeglanoside
and nigelloside could be used as markers to differentiate both
species (Yun et al., 2014).
Saponins
Other studies also suggest the presence of phenolic compounds and
triterpenes like saponins in the seeds of N. sativa and other Nigella
species (Ali et al., 2008; Atta Ur, 1985; Atta Ur, 1992; El-Naggar et al.,
2017; Kooti et al., 2016; Tiruppur Venkatachallam et al., 2010; Zribi
et al., 2014). Saponins are a heterogeneous group of glycosides, which
have one or more hydrophilic moieties combined with a lipophilic
triterpene or steroid derivative. In particular, triterpene saponins are
TABLE 2 | Main volatile compounds in essential oils from Nigella seeds.
Compound name Source (origin) Relative amount (%) References
Thymoquinone N. damascena (M), N. sativa seed (C), N. sativa seed (T), N.
sativa seed (I), N. sativa seed (tk, E), N. sativa seed (ir), N.
sativa seed (T), N. sativa seed (M)
0.1, 3.7, 3.0, 33.1–38.4a,
77.2–86.2b, 0.6, ND, 3.8
(Bourgou et al., 2010b; Geng et al., 2009; Jrah
Harzallah et al. (2011); Moretti et al., 2004; (Piras et al.,
2013)
p-Cymene N. damascena (M), N. sativa seed (C), N. sativa seed (T), N.
sativa seed (I), N. sativa seed (tk, E), N. sativa seed (ir), N.
sativa seed (T), N. sativa seed (M)
ND, 33.8, 60.5, ND, ND,
14.8, 49.5, 33.8
(Bourgou et al., 2010b; Geng et al., 2009; Jrah
Harzallah et al. (2011); Moretti et al., 2004; (Piras et al.,
2013)
Dithymoquinone N. damascena (M), N. sativa seed (T), N. sativa seed (I), N.
sativa seed (tk, E), N. sativa seed (ir), N. sativa seed (T), N.
sativa seed (M)
ND, ND, ND, ND, ND, ND (Bourgou et al., 2010b; Jrah Harzallah et al. (2011);
Moretti et al., 2004; (Piras et al., 2013)
Thymohydroquinone N. damascena (M), N. sativa seed (T), N. sativa seed (I), N.
sativa seed (tk, E), N. sativa seed (ir), N. sativa seed (T), N.
sativa seed (M)
ND, 0.4, 1.1–2.3a, ND,
ND, ND
(Bourgou et al., 2010b; Jrah Harzallah et al. (2011);
Moretti et al., 2004; (Piras et al., 2013)
Carvacrol N. damascena (M), N. sativa seed (T), N. sativa seed (I), N.
sativa seed (tk, E), N. sativa seed (ir), N. sativa seed (T), N.
sativa seed (M)
ND, 2.4, 0.8–2.0a, ND-7.9,
1.6, 0.6, ND
(Bourgou et al., 2010b; Jrah Harzallah et al. (2011);
Moretti et al., 2004; (Piras et al., 2013)
Thymol N. damascena (M), N. sativa seed (T), N. sativa seed (I), N.
sativa seed (tk, E), N. sativa seed (ir), N. sativa seed (T), N.
sativa seed (M)
ND, ND, 5.3–17.0a, ND,
ND, 26.8
(Bourgou et al., 2010b; Jrah Harzallah et al. (2011);
Moretti et al., 2004; (Piras et al., 2013)
α-Thujene N. damascena (M), N. sativa seed (T), N. sativa seed (I), N.
sativa seed (tk, E), N. sativa seed (ir), N. sativa seed (T), N.
sativa seed (M)
ND, 6.9, ND, ND-0.4b, 2.4,
18.9, 3.3
(Bourgou et al., 2010b; Jrah Harzallah et al. (2011);
Moretti et al., 2004; (Piras et al., 2013)
α-Pinene N. damascena (M), N. sativa seed (T), N. sativa seed (I), N.
sativa seed (tk, E), N. sativa seed (ir), N. sativa seed (T), N.
sativa seed (M)
ND, 1.7, ND, ND, 1.2, 1.2,
5.4, 0.7
(Bourgou et al., 2010b; Jrah Harzallah et al. (2011);
Moretti et al., 2004; (Piras et al., 2013)
β-Pinene N. damascena (M), N. sativa seed (T), N. sativa seed (I), N.
sativa seed (tk, E), N. sativa seed (ir), N. sativa seed (T), N.
sativa seed (M)
ND, 2.4, ND-0.4a, ND, 1.3,
4.3, 1.1
(Bourgou et al., 2010b; Jrah Harzallah et al. (2011);
Moretti et al., 2004; (Piras et al., 2013)
γ-Terpinene N. damascena (M), N. sativa seed (T), N. sativa seed (I), N.
sativa seed (tk, E), N. sativa seed (ir), N. sativa seed (T), N.
sativa seed (M)
ND, 3.5, 12.9–27.5a, ND-
0.6b, 0.5, 2.5, 2.4
(Bourgou et al., 2010b; Jrah Harzallah et al. (2011);
Moretti et al., 2004; (Piras et al., 2013)
trans-Anethole N. damascena (M), N. sativa seed (T), N. sativa seed (I), N.
sativa seed (tk, E), N. sativa seed (ir), N. sativa seed (T), N.
sativa seed (M)
Tr, ND, ND, ND, 38.3 (Bourgou et al., 2010b; Jrah Harzallah et al. (2011);
Moretti et al., 2004; (Piras et al., 2013)
β-Elemene N. arvensis seed, N. damascena seed (M), N. sativa
seed (M)
69.0, 73.2, 5.5 (Moretti et al., 2004; Edris, 2009)
ND, Not detected/reported; C, China; I, India; Ir, Iran; E, Egypt; M, Morocco; T, Tunisia; Tk, Turkey; Tr, traces.
aDepending on the extraction method and conditions.
bDepending on the origin.
Frontiers in Pharmacology | www.frontiersin.org April 2021 | Volume 12 | Article 6253866
Salehi et al. A Comprehensive Review on Nigella Plants
FIGURE 3 | Example of chemical structures of alkaloids and saponins reported in N. sativa.
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highly characteristic compounds in Nigella seeds. Besides alpha-
hederin (30) (Boubertakh et al., 2013), other relative saponins are:
3-O-[D-xylopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)-α-L-arabi
npyranosyl]-28-O-[-α-L-rhamnopyranosyl-(1→4)-β-D-glucopyra
nosyl-(1→6)-β-D-glucopyranosyl] hederagenin (nigella A) (31),
3-O-[D-xylopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)-α-L-arab
inpyranosyl]-28-O-β-D-glucopyranosyl hederagenin (nigella B) (32),
3-O-[α-L-rhamnopyranosyl-(1→2)-α-L-arabinpyranosyl]-28-O-
[β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl] hederagenin
(nigella C) (33), 3-O-[D-xylopyranosyl-(1→3)-α-L-rhamnopyranosyl-
(1→2)-α-L-arabinpyranosyl]-28-O-[-α-L-rhamnopyranosyl-(1→4)-
β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl] hederagenin
(nigella D) 34) (Figure 3). The latter were reported in the seeds
of N. sativa and exhibit a broad spectrum of bioactivities (Chen
et al., 2018; Dönmez and Mutlu, 2004). Others also found
in the latter species are: 3-O-[L-rhamnopyranosyl-(1→2)-
L-arabinopyranosyl]-hederagenin (kalopanaxsaponin A) (35)
and 3-O-[-D-xylopyranosyl-(1→3)-L-rhamnopyranosyl-(1→2)-
L-arabinopyranosyl]-hederagenin (kalopanaxsaponin I) (36)
(Figure 3), with anticancer properties reported in vitro (Tian
et al., 2006).
Phenolic Compounds
Concerning phenolic compounds, a recent study suggested that
N. sativa, N. arvensis, N. damascena, and N. hispanica seeds have
more flavonoids and phenolic acid derivatives than N.
nigellastrum and N. orientalis seeds (Farag et al., 2014).
Phenolic compounds are characterized to be small molecules
with at least one phenol unit. Some common ones have been
reported in the seeds of N. sativa seeds, e.g. kaempferol (37),
quercetin (38), rutin (39), salicylic acid (40), p-hydroxybenzoic
acid (41), methyl-4-hydroxybenzoate (42) and pyrogallol (43)
(Xin et al., 2008; Boubertakh et al., 2013) (Figure 4). Table 3
shows examples of phenolic compounds described in Nigella
plants and their contents.
Kaempferol and quercetin derivatives are also common in other
Nigella species (Farag et al., 2014). Moreover, characteristic
glycosilated flavonoids, also found in the seeds, are: kaempferol
3-O-beta-D-galactopyranosyl-(1→3)-beta-D-glucopyranosyl(1→3)-




D-galactopyranosyl-(1→2)-O-D-glucopyranoside 46) (Figure 4),
which were reported in N. sativa (Liu et al., 2011; Xin et al.,
2008) (Figure 4). The latter flavonoid is a taxonomic marker for
distinguishing N. sativa from other Nigella species (Farag et al.,
2014).
Methanolic extracts from seeds, shoots and roots of TunisianN.
sativa contained phenolic compounds, including: gallic acid (47),
p-hydroxybenzoic acid (41), vanillic acid (48), syringic acid (49),
(–)-epicatechin (50), (+)-catechin (51), chlorogenic acid (52),
p-coumaric acid (53), ferulic acid (54), trans-2-hydroxycinnamic
acid (55), trans-cinnamic acid (56), quercetin (38), apigenin (57),
and amentoflavone (58) (Figure 4). Nonetheless, among them,
vanillic acid (48) was the major phenolic compound (Bourgou
et al., 2008; Bourgou et al., 2010a).
A recent study has shown that there are qualitative and
quantitative differences between the phenolic compounds of
ethanolic extracts from N. sativa and N. damascena seeds
(Toma et al., 2015). For example, quercitrin (59) was
detected in both extracts, hyperoside (60) and quercetin
(38) in N. damascena, while kaempferol (37) was found
only in N. sativa. Moreover, a recent study has reported a
more complex phenolic profile, which was found complexed
with N. damascena seeds proteins: gallic acid (47),
protocatechuic acid (61), 2,5-dihydroxybenzoic acid (62),
vanillic acid (48), (+)-catechin (51), caffeic acid (63),
chlorogenic acid (52), syringic acid (49), (–)-epicatechin
(50), p-coumaric acid (53), sinapic acid (64), hesperidin
(65), quercetin 38) and kaempferol (37).
Some of these compounds were also present in N. arvensis
seeds (Alu’datt et al., 2016), while 7-methylkaempferol
(rhamnocitrin) was also reported in the epigeal part of this
species (Kirichenko et al., 1972). Other type of phenolic
compounds reported in N. damascena seeds were
hydroxytyrosol (66), 2,4-dihydroxyphenylacetic acid (67) and
its methyl derivative (68), as well as a new phenolic ester, 1-
O-(2,4-dihydroxy) benzoylglycerol 69) (Fico et al., 2000)
(Figure 4).
Others
Examples of other reported terpene chemicals include
phytosterols such as β-sitosterol (70), Δ5-avenasterol (71), and
Δ7-avenasterol (72), as well as stanols such as cycloartenol (73)
(Figure 5). Other triterpenes like β-amyrin (74) and
butyrospermol (75) (Ramadan and Mörsel, 2002; Ahmad
et al., 2013; Ijaz et al., 2017), as well as α-tocopherol (76),
γ-tocopherol (77), and β-carotene (78) are also found in seeds
(Ramadan and Mörsel, 2004) (Figure 5).
Factors that Affect the Phytochemical
Composition
Phytoconstituents of Nigellamay vary even within the same species
and this is related to many factors such as growing and climatic
conditions, location, different organs of the plants and the extraction
methods used (Edris, 2010; Manju et al., 2016; Saxena et al., 2017)
(Tables 2 and 3). Secondary metabolites, compounds which are not
directly related to the development, growth and reproduction of
plants but they have significant performance in chemical
communication, primary defense against biotic and abiotic stress
(Sarkar and Shetty, 2014) and also in epigenetic memory. The
chemical composition may vary also during development stage
and this was confirmed by Zribi et al. (2014) who demonstrated
that the total phenolics, flavonoids, flavonols and flavones, alkaloids
and proanthocyanidins contents of Tunisian and Indian N. sativa
aqueous extracts were the highest in the vegetative stage. Moreover,
the aerial parts from the two varieties were richer in total phenolics
and flavonoids, including flavonols, flavones and proanthocyanidins,
than seeds. Salinity is also another factor that greatly influenced the
phenolic composition of Nigella seeds; e.g. generally the content of
certain phenolic compounds decreased, including the major one
vanillic acid (45), while the content of trans-cinnamic acid (53),
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FIGURE 4 | Example of chemical structures of phenolic compouds reported in N. glandulifera, N. sativa, N. damascena, and N. arvensis.
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quercetin (38), and apigenin (54) increased. This was related with a
decrease of the antioxidant activity (Bourgou et al., 2010a). Today,
this is essential information since water scarcity and salinization of
arable lands may occur in a future scenario exposed to drastic
changes caused by climate (Selim et al., 2019), affecting not only crop
growth but also its phytochemical content and antioxidant
properties.
This means that a high variability in the content of
phytochemicals can be found in Nigella plant parts, and in
particular in N. sativa seeds, and from a functional point of
view each essential oil/extract should be further characterized in
order to elucidate the real active molecules inside for further
standardization and quality control.
BIOLOGICAL ACTIVITIES: PRECLINICAL IN
VITRO/IN VIVO STUDIES OF THE GENUS
NIGELLA AND ACTIVE COMPOUNDS
This section collects the results of in vitro, ex vivo, and in vivo
studies on the antioxidant, anticancer, cardioprotective,
antidiabetic, antiobesity and neurological properties of Nigella
species, mainly, N. sativa, as well as some active principles,
including thymoquinone.
Antioxidant Activity and Effects on
Oxidative Stress
Some studies suggest that N. sativa oil and extracts have
antioxidant properties and can modulate oxidative stress,
which could be beneficial for oxidative stress related diseases/
disorders. In this sense, oils and solvent extracts from N. sativa
seeds possessed antioxidant activity in vitro (Toma et al., 2015;
Mohammed et al., 2016; Abedi et al., 2017; Singhal et al., 2017), ex
vivo (Ghoreyshi et al., 2020), in vivo (Mahmoudi et al., 2018;
Rasoli et al., 2018) and in humans (Nikkhah-Bodaghi et al., 2019).
Moreover, in vivo regular intake of ethanolic extract of N. sativa
seed (400 mg/kg) lowered the lipid peroxidation, and enhanced
catalase activity in Wistar rats (Rasoli et al., 2018). Another work
suggested that hydroalcoholic and hexane extracts of N. sativa
seed as well as thymoquinone may counteract oxidative stress
caused by high-fat diets (HFDs), e.g. malondialdehyde (MDA)
TABLE 3 | Example of phenolic compounds found in Nigella species.
Compound name Source (origin) Amount (mg/g) References
p-Hydroxybenzoic acid N. sativa seed (C), N. sativa seed (T) NR, 0.002 (Bourgou et al., 2008;
Bourgou et al., 2010a)
Gallic acid N. sativa seed (T), shoot (T), root (T) 0.3–1.0a, 0.3, 0.3 (Bourgou et al., 2008;
Bourgou et al., 2010a)
Chlorogenic acid N. sativa seed (T), shoot (T), root (T) 0.02–0.04a, 0.015,
0.004
(Bourgou et al., 2008;
Bourgou et al., 2010a)
Syringic acid N. sativa seed (T) 0.01–0.02a (Bourgou et al., 2008;
Bourgou et al., 2010a)
Vanillic acid N. sativa seed (T), shoot (T), root (T) 2.2–3.5a, 1.4, 0.9 (Bourgou et al., 2008;
Bourgou et al., 2010a)
p-Coumaric acid N. sativa seed (T), root (T) 0.01–0.02a, 0.004 (Bourgou et al., 2008;
Bourgou et al., 2010a)
Ferulic acid N. sativa seed (T), root (T) 0.04–0.13a, 0.002 (Bourgou et al., 2008;
Bourgou et al., 2010a)
trans-Cinnamic acid N. sativa seed (T), shoot (T), root (T) 0.03–0.05a, 0.2, 0.01 (Bourgou et al., 2008;
Bourgou et al., 2010a)
(–)-Epicatechin N. sativa seed (T), shoot (T), root (T) 0.01–0.02a, 0.01, 0.01 (Bourgou et al., 2008;
Bourgou et al., 2010a)
(+)-catechin N. sativa seed (T) 0.1–0.3a (Bourgou et al., 2008;
Bourgou et al., 2010a)
Quercetin N. sativa seed (C), N. sativa seed (T), shoot (T), root (T) NR, 0.002–0.005a,
0.03, 0.03
(Bourgou et al., 2008;
Bourgou et al., 2010a)
Apigenin N. sativa seed (T), shoot (T), root (T) 0.003–0.005a,
0.07, 0.02
(Bourgou et al., 2008;
Bourgou et al., 2010a)
Amentoflavone N. sativa seed (T), shoot (T) 0–0.001a, 0.03 (Bourgou et al., 2008;
Bourgou et al., 2010a)
Quercetin N. damascena seed (R), N. damascena seed (J), N. arvensis
seed (J)
0.014, NR, NR (Toma et al., 2015)
Quercitrin N. damascena seed (R), N. sativa seed (R) 0.020, 0.004 (Toma et al., 2015)
Hyperoside N. damascena seed (R) 0.001 (Toma et al., 2015)
Kaempferol N. arvensis seed (J), N. damascena seed (J), N. sativa seed
(C), N. sativa seed (R)
0.006, NR, NR, NR (Toma et al., 2015)
Kaempferol-3-O-[β-D-glucopyranosyl-(1ê2)-
β-D-galactopyranosyl-(1ê2)-β-D-glucopyranoside]
N. arvensis seed (G), N. damascena seed (A, I), N. sativa
seed (C), N. hispanica seed (G, F), N. nigellastrum seed (CR),
N. orientalis seed (tk), N. sativa seed (E, et, S, SA, tk)
ND, tr, ND, ND, tr,
3.4–6.1a, NR
(Farag et al., 2014)
A, Austria; C, China; CR, Czech Republic; E, Egypt; Et, Ethiopia; F, France; G, Germany; I, Italy; J, Jordan; NR, Not reported; R, Romania; S, Syria; T, Tunisia; Tk, Turkey; SA, Saudi Arabia.
aIt depends on the salinity tested.
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levels decreased, while the activity of catalase enzyme and serum
total antioxidant capacity increased (Mahmoudi et al., 2018).
Concerning other Nigella species, N. damacena 70% ethanolic
extract (seeds) has shown antioxidant properties in vitro, even
higher generally than N. sativa seeds (Toma et al., 2015); the
former contained higher amounts of quercetin derivatives. Also,
the fixed oil from the seeds of another species, Nigella
unguicularis Spenner, showed favorable oxidant/antioxidant
balance and blood lipids profile when it was administered to
rats (1 ml/kg orally for 4 weeks) (Kökdil et al., 2005). However,
the responsible active compounds were not determined in the
latter case.
As commented before, thymoquinone can have a protective role
against oxidative stress (Woo et al., 2013). Thymoquine has shown
antioxidant properties in vitro, in particular using the oxygen
radical absorbance capacity (Tesarova et al., 2011). Essential oil
extracted from N. sativa seeds with higher thymoquinone content
showed stronger antioxidant activity than other essential oils
(Abedi et al., 2017). In this context, Usta and Dede (2017)
assessed role of thymoquinone on oxidative DNA damage and
NF-κB levels in diabetic rats. The results revealed that the oxidative
DNA damage (8 hydroxy-2-deoxyguanosine) and NF-κB levels
were insignificantly lowered after treatment. Moreover, it also
reduced glycosylated hemoglobin, glucose levels and aspartate
aminotransferase (AST), alanine aminotransferase and gamma-
glutamyl transpeptidase activities. In recent in vitro and in vivo
studies, thymoquinone in combination with iron oxide
nanoparticles showed attenuation in genetic and oxidative
damage, and caused an enhancement in the levels of anti-
oxidant enzymes (Ansari et al., 2019).
Nonetheless, other Nigella phytochemicals constituents have
antioxidant activity, which is not strictly dependent on the
FIGURE 5 | Example of phytosterols and stanols reported and other terpenes in Nigella.
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thymoquinone content (Bordoni et al., 2019).
Thymohydroquinone (11) has also shown scavenging properties
in vitro, while no effects were found for dithymoquinone (10)
(Tesarova et al., 2011). Trans-anethole (14), isolated from the
essential oil of N. sativa seeds by thin-layer chromatography,
also showed free radical scavenging properties using several
methods (Burits and Bucar, 2000). Moreover, the phenolic
nature of thymol (13) and carvacrol (12) makes them to possess
higher antioxidant activity than other volatile constituents in oils
(see reviews by (Salehi et al., 2018; Sharifi-Rad et al., 2018; Salehi
et al., 2019). In an antioxidant activity guided fractionation of the
essential oil from N. sativa seeds it was found that thymoquinone
11) (51%), thymol (25%) and carvacrol (8%) were the main
antioxidant compounds (Kazemi, 2015). Moreover, in oxidative
stress induced experimental subjects, thymol (12) (thymol
10 mg/kg) has been shown significant impact on sperm quality
via increasing the spermatozoa concentration and motility, and
lowering the MDA level. It also decreases the dead sperm ratio and
enhances the glutathione concentrations in the testicles, liver and
kidney tissues (Fangfang et al., 2017). The antioxidative properties
of thymol (12) and carvacrol (13), through improving the
antioxidants, suppressing lipid peroxidation markers and
ameliorating oxidative stress, have also been shown in other in
vivo studies (Bakir et al., 2016; Samarghandian et al., 2016;
Saravanan and Pari, 2016).
It should be notice that polar extracts from Nigella could have
a wide spectrum of other phenolic compounds, which are
antioxidant in nature (see section 4.5), and thus it should be
taken into account in further studies. As an example, free and
bound phenolic compounds, which were associated to N.
damascena and N. arvensis proteins from the seeds, have
shown antioxidant properties in vitro (Alu’datt et al., 2016).
As noted before, N. damascena seeds contain quercetin
derivatives, including quercetin aglycone, hyperoside and
quercitrin, as well as the total phenolic content showed
enhanced antioxidant properties (Toma et al., 2015).
Furthermore, total saponins from N. sativa seeds increased the
plasma superoxide dismutase (SOD) and glutathione peroxidase
(GSH-Px) activities and decreased MDA level compared to
control group in D-galactose-induced aging model
(6–24 mg/kg). These seeds also showed (2,2-diphenyl-1-
picrylhydrazyl) DPPH radical scavenging properties (Dönmez
and Mutlu, 2004).
Anti-cancer Properties
Nigella sativa has anti-proliferative, pro-apoptotic, anti-oxidant,
cytotoxic, anti-mutagenic, and anti-metastatic effects, underlined
by several mechanisms reviewed by (Majdalawieh and Fayyad,
2016). Studies in cell lines, including in human lung (A-549 cells),
epithelial cervical (HeLa and SiHa) and Michigan Cancer
Foundation-7 (MCF-7) breast cancer cells, have shown that
the administration of N. sativa alcoholic seed extracts, seed oil
and nanoemulsions markedly lowered the cell viability, inducing
apoptotic cell death, and/or altered the cellular morphology, with
IC50 values between 0.41-82 μL/mL in some cases (Shafi et al.,
2009; Hasan et al., 2013; Al-Sheddi et al., 2014; Periasamy et al.,
2016; Butt et al., 2019). Among these studies, Hasan et al. (2013)
revealed the presence of thymoquinone as the potential active
Nigella constituent. Concerning in vivo studies, supplementation
of different doses of N. sativa ethanolic extract (seed) on daily
basis (150, 250, 350 mg/kg), thymoquinone (20 mg/kg), and daily
dose of silymarin (100 mg/kg) prevented from the hepatocellular
carcinoma proliferation provoked by diethylnitrosamine through
multiple pathways: reduction in p-EGFR and p-ERK1/2,
deactivation of EGFR/ERK1/2 signaling, down regulation of
target genes (c−fos, PCNA, and Bcl2), suppression of cell
proliferation, reduction in alpha-fetoprotein (AFP) and hepatic
enzymes, and enhancement in the levels of antioxidant enzymes
(Shahin et al., 2018). Other in vivo studies suggested a protective
effect of N. sativa seeds oil and thymoquinone against breast
carcinogens (Linjawi et al., 2015) with dosages between 1 and
10 mg/kg. The water extract of N. sativa has shown
immunomodulatory and anti-tumor effects on Ehrlich ascites
carcinoma in mouse model (Aikemu et al., 2013), but its
composition was not characterized.
Thymoquinone is one of the potential active compounds in
Nigella, as commented before (Woo et al., 2012; Siveen et al., 2014;
Shanmugam et al., 2018a; Shanmugam et al., 2018b). It also
demonstrated anti-tumor activity on human liver HepG2 cancer
cells lines (IC50  46 μM) by: enhanced caspase-3 enzyme activity,
decreasedMDA contents, induced cell apoptosis, and inhibited cell
growth (Ismail et al., 2018). This compound also revealed to be a
potential therapeutic adjuvant in human breast cancer cell lines
(MCF-7, IC50  64.93 µM, and T47D, IC50  165 µM). In other
cases, thymoquinone in combination with anti-cancer drugs, can
exhibit antagonistic and synergistic effects (Bashmil et al., 2018).
Nonetheless, as shown in “Phytoconstituents” section, Nigella
genus is a rich source of phytochemicals, including
dithymoquinone (10), thymohydroquinone (11), carvacrol (12),
thymol (13), nigellimine-N-oxide (24), nigellicine (25), nigellidine
(27), which may contribute to the anticancer properties (see
reviews by Majdalawieh and Fayyad, 2016; Salehi et al., 2018;
Sharifi-Rad et al., 2018; Salehi et al., 2019). Edris (2009) also
remarked that β-elemene (17), which is one of the most
abundant compounds in Nigella species like N. orientalis, N.
damascena, and N. arvensis, has also anti-cancer properties.
Moreover, recent studies suggest that Nigella saponins,
including α-hederin (30), nigella A (31) and B (32), have an
anti-cancer protective role (Chen et al., 2018; Dönmez and
Mutlu, 2004; Kumara and Huat, 2001; Rooney and Ryan, 2005;
Tian et al., 2006). Remarkably, nigella A (31) and B (32) (40 mg/kg,
intragastric administration), extracted from N. sativa, inhibited
tumor growth in nude mice by 42.82 and 37.20%, respectively,
when compared with vehicle-administered animals (Chen et al.,
2018). Furthermore, phenolic derivatives isolated in the seeds ofN.
sativa, salfredin B11 (79), nigephenol A (80) and B (81), and
nigephenol C (82) (Figure 6), showed inhibition against HepG2
cells (Sun et al., 2015). Globally, seeds, their extracts and essential
oils from Nigella are complex sources of anti-cancer compounds,
whose level and synergism/antagonism require further study.
Cardioprotective Properties
Nigella sativa has a high potential for the prevention and
treatment of cardiovascular diseases, while little is known
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about the cardiovascular properties of otherNigella species. As an
example, N. sativa seeds powder improved lipid profile and
prevented atherosclerosis in hypercholesterolemic rabbits when
it was supplied in their diet (5%). It significantly decreased fatty
streak formation, total cholesterol and low-density lipoprotein
(LDL) (Asgary et al., 2013). A recent study also suggests that
diabetic rats treated with an ethanolic extract fromN. sativa seeds
(100–400 mg/kg) for six weeks reduced serum glucose and lipids,
while it improved atherogenic index of plasma, vasoreactivity,
endothelial dysfunction, and vascular inflammation
(Abbasnezhad et al., 2019). Nigella sativa (seed, oil and
extracts) has a potential role in the management of
hypertension, as shown ex vivo (Hebi et al., 2016;
Abbasnezhad et al., 2019) and in vivo studies (Khattab and
Nagi, 2007; Leong et al., 2013; Enayatfard et al., 2018) due to
vasorelaxant properties. It also may increase endothelial nitric
oxide (NO) synthesis, attenuate cardiovascular effects of the
vasoconstrictor angiotensin II, and inhibit the parasympathetic
tone (Khattab and Nagi, 2007).
Nigella sativa seed oil used in the study by Asgary et al. (2013)
contained predominantly terpenoids, including p-cymene 9)
(37.3%) and thymoquinone 8) (13.7%). In other studies, N.
sativa seeds extracts contained thymoquinone (8), which were
standardized (0.05–0.06% extract weight) (Enayatfard et al., 2018;
Abbasnezhad et al., 2019). In fact, thymoquinone has
demonstrated very good cardioprotective benefits and
antihypertensive effects (Enayatfard et al., 2018). Liu et al.
(2019) reported that thymoquinone has protective effects
against cardiac damage in BALB/c mice via multiple
mechanisms including reduction in intestinal histological
alterations, suppressions of p62, NLRP3, IL-1β, TNF-α,
caspase-1, IL-6 and 18, as well as MCP-1 expressions,
inhibition of troponin-T levels in serum, enhancement in
ATP, improvement in IL-10 and beclin 1 levels, and
decrement in phosphatidylinositide 3-kinase level.
Convincingly, thymoquinone effectively modulates pyroptosis,
autophagy, and pro-inflammatory markers in cardiac stress (Liu
et al., 2019). Likewise, thymoquinone reverted doxorubicine-
induced cardiotoxicity when administered to mice. of the
administration of thymoquinone (10–20 mg/kg p.o)
significantly ameliorated oxidative stress markers involving
lipid peroxidation, creatine kinase (CK)-MB, lactate
FIGURE 6 | Chemical structure of salfredin B11, nigephenol A-C and of nigelladine A–C and nigellaquinomine.
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dehydrogenase (LDH), and AST. Alongside, meaningful
improvement in antioxidant enzymes like SOD, catalase,
glutathione reductase, and glutathione-S-transferase has also
been noticed (Alam et al., 2018). Another recent study
reported by Atta et al. (2018) showed the protective role of
thymoquinone on diabetes-caused cardiac complications in
Wistar male rats. Lu et al. (2018) reported that thymoquinone
(8) provides shield against myocardial ischemia/reperfusion (I/R)
injury in isolated rat hearts and neonatal rat cardiomyocytes
models via: improving left ventricular function, lowering
myocardial infarct size, attenuating mitochondrial oxidative
damage, producing LDH, and lowering MDA levels and H2O2
concentrations, alongside improving antioxidant enzymes levels.
Additionally, the cardioprotective role of this compound was also
linked to the up-regulation of sirtuin 1 (SIRT1) expression and
inhibition of p53 acetylation (Lu et al., 2018). Thymoquinone 8)
showed prophylactic effect from myocardial I/R injury in
Langendorff perfused rat hearts. It encouraged autophagy,
favored cardiac function, lowered infarct size, LDH and CK-
MB levels, and suppressed oxidative stress (Xiao et al., 2018).
Finally, Salahshoor and their co-workers highlighted that the
supplementation of thymoquinone (4.5–18 mg/kg) in mice
significantly increased the mean diameter of central hepatic
vein, blood serum NO level, and liver enzymes level, while it
decreased the liver weight (Salahshoor et al., 2018).
Two other interesting molecules are again carvacrol (12) and
thymol (13). The latter was a cardioprotective agent against carotid
tissue of hypercholesterolemic rats. The supplementation of
thymol (24 mg/kg) in experimental subjects prevents from
cardio complications through several mechanisms such as
reduction in low density lipoprotein, triglycerides, increment in
high-density lipoprotein level, reduction in apoptotic proteins and
inflammatory expressions, phosphorylation of p38 (p-p38) and the
protein expression of cleaved caspase-3 (Bayatmakoo et al., 2017).
In another work, thymol (13) administration (7.5 mg/kg) reversed
changes produced by isoproterenol in rats. It also enhanced the
caspase-8 and 9, as well as Fas genes expression while lowered Bcl-
xL gene expression in myocardium (Meeran et al., 2016). Among
other effects, previous investigation revealed that multiple
pathways are involved in this effect: a lowered serum cardiac
troponin-Y, lysosomal thiobarbituric acid reactive substances
(TBARS), high sensitivity C-reactive protein (hsCRP), and
lowered activities of β-glucuronidase, β-galactosidase, cathepsin-
B and D activities in lysosomes. Thymol down-regulated the
proinflammatory cytokines involving IL-6 and 1β genes
expression and TNF-α in myocardium of rats, and lowered
heart weight, left ventricular hypertrophy and increased ST
segments and tachycardia (Nagoor Meeran et al., 2015a; Nagoor
Meeran et al., 2015b; Nagoor Meeran et al., 2016). El-Sayed et al.
(2016) evidenced the protective role of both thymol (13) (20 mg/kg
p.o.) and/or carvacrol (12) (25 mg/kg) against doxorubicin induced
cardiotoxicity, ameliorating the heart function and oxidative stress
parameters.
Antidiabetic
Nigella sativa could play a role against diabetes and obesity, and
thereby it could be an interesting agent to treat/prevent the
metabolic syndrome. In cell in vitro assays, the ethanol extract
from N. sativa seeds has shown antidiabetic activity using
adipocytes (Benhaddou-Andaloussi et al., 2008; Benhaddou-
Andaloussi et al., 2010). In particular, it was able to activate
the AMPK pathway and the insulin signaling pathway, as well as
it acted as an agonist of the peroxisome proliferator-activated
receptor (PPARγ) (Benhaddou-Andaloussi et al., 2010), which
plays a role in the regulation of metabolism. The seed oil from N.
sativa, which contained compounds such as thymoquinone (8),
anethole (14), p-cymene (9), saturated and unsaturated fatty
acids, had also antidiabetic properties in vivo. In this concern,
N. sativa oil (500 mg/kg/day) was co-administered orally along
with high-fructose water (20%, w/v) for 45 days. It was able to
reduce fructose-induced insulin resistance by reduction of
hepatic insulin-degrading enzyme protein and activation of
insulin receptor signaling. It also decreased body weight (BW),
serum lipids, and glucagon (Elseweidy et al., 2018). In addition,
n-hexane and petroleum ether from the seeds of N. sativa has
shown inhibitory properties against protein tyrosine phosphatase
1B, with half maximal inhibitory concentration values of 33.15
and 18.50 μg/mL, respectively. This could be another mechanism
of action since this enzyme is involved in the down regulation of
insulin and leptin signaling and thus this plant could have
antidiabetic potential (Xin et al., 2010).
Among the bioactive constituents of Nigella, the antidiabetic
and antiobesity properties of thymoquinone have been also
revealed. The administration (20 mg/kg/day) to diet-induced
obesity mice was able to reduce decrease fasting blood glucose
(FBG) and insulin levels, and enhanced glucose tolerance and
insulin sensitivity. Moreover, this compound decreased the
level of liver triglycerides and serum cholesterol, increased
protein expression of phosphorylated Akt, decreased serum
levels of inflammatory markers, and decreased NADH/NAD+
ratio. It was related to the capacity of thymoquinone to increase
insulin sensitivity in insulin-resistant HepG2 cells through a
SIRT1-dependent mechanism (Karandrea et al., 2017).
Glycemic parameters were momentously controlled by the
administration of thymoquinone (8) to the diabetic rats
(Usta and Dede, 2017). El-Aarag et al. (2017) also
investigated the effects of this compound to boost anti-
diabetic properties of metformin in streptozotocin-induced
diabetes in male rats. Their investigation unveiled that
negative impacts of streptozotocin were corrected and
normal biochemical functions were restored by combined
treatment of thymoquinone (8) and metformin. This
combination also up-regulated the expression level of
glucose transporter-2 (Glut-2). The elevated MDA level was
reduced in liver homogenates of the thymoquinone (8) treated
rats (Zribi et al., 2014). Thymoquinone (8) in nano-formulation
(20–80 mg/kg) showed significant decrease in blood glucose
and HbA1c levels and showed a dose dependent
antihyperglycemic effect. It can result in better
antihyperglycemic effect in type-2 diabetic rats than the
non-capsulated compound (Rani et al., 2018). In another
research, intraperitoneal administration of thymoquinone (8)
(50 mg/kg) resulted in amelioration of dyslipidemia,
hypoinsulinemia, hyperglycemia, impaired antioxidant
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defense system and upregulation of the expression of PPAR-γ
and GLUT4 genes in diabetic rats (Moneim et al., 2018).
Concerning thymol (13), intragastric administration (40 mg/kg/
day) for the subsequent 5 weeks momentously lowered kidney
weight and blood and urinary markers of kidney injury by HFD-
induced nephropathy in diabetic mice (Saravanan and Pari, 2016).
It further reduced the HbA1c, leptin and adiponectin levels in the
mice receiving thymol treatment. The plasma triglyceride,
cholesterol, LDL and free fatty acids were reported to be
significantly lowered and HDL was momentously elevated in
thymol treated mice (Saravanan and Pari, 2016). It also
represented beneficial effects on HFD-induced cognitive deficits
via activating Nrf2/HO-1 signaling and improving hippocampal
insulin resistance (Fangfang et al., 2017). The neuroprotective
effect of carvacrol (12) has been also demonstrated on diabetes-
associated cognitive deficit in a rat model of diabetes treated with
this compound (25–100 mg/kg, 7 weeks). It prevented behavioral,
biochemical, and molecular changes associated with diabetes in a
dose-dependently way (Deng et al., 2013).
However, the aforementioned in vitro study on adipocytes
(Benhaddou-Andaloussi et al., 2010) suggests that compounds
other than thymol, such as carvacrol (12), hederin (30),
nigellimine (23), and thymoquinone (8), could be active forms.
In this regards, four alkaloids, nigelladines A–C (83–85) and
nigellaquinomine 86) (Figure 6) have been isolated in N. sativa
seeds and possessed inhibitory activity protein tyrosine
phosphatase 1B (PTP1B) inhibitory activity, which is key
negative regulator of insulin signaling (Chen et al., 2014).
Active n-hexane and petroleum ether extracts from this plant
were also rich in palmitic acid and unsaturated fatty acids like
oleic and linoleic acids, and their methyl esters (Xin et al., 2010).
Antiobesity
Nigella sativa fruit and seed extracts and oil (33% thymoquinone)
have shown antiobesity potential using in vitro and in vivo
studies, and the mechanisms include the inhibition of
pancreatic lipase and α-amylase (15–100%, depending on the
extract and enzyme), proinflammatory cytokine production in
pre-adipocytes (a model of low-grade inflammation in
Simpson–Golabi–Behmel syndrome human) and weight loss,
by positively affecting the uncoupling protein-1 (UCP-1),
which the index protein of the brown adipose tissue used in
the obesity studies (Buchholz and Melzig, 2016; Mahmoudi et al.,
2018; Bordoni et al., 2019).
The latter in vivo study, which was performed in mice feed with
HFD, suggested that the weight loss effect was less dependent on
tymoquinone, while other phenolic compounds may affect
(Mahmoudi et al., 2018). Alternatively, studies on female C57BL/
6 mice, which were also subjected to HFD and supplemented with
thymoquinone (10–20%), showed that this compound ameliorated
obesity-induced metabolic dysfunction and impaired positive effects
on ovarian and mammary gland metabolic functions (Harphoush
et al., 2019). In another context, obesity markers were significantly
down-regulated while momentous control over obesity-induced
changes in biochemical profile of the body by thymol (13)
treatment. It also modified fat and glucose metabolism in such a
way to favor the control over obesity in mice partly via
hypolipidemic, hypoglycemic, hypo-insulinemic, hypoleptinemic,
and pancreatic lipase inhibition action (Haque and Ansari, 2018).
This compound has also been endorsed to possess anti-obesity
properties by controlling obesity markers in HFD induced obese
male Wistar rats. They recorded significant reduction in body and
liver weights, visceral fat pad weight, food intake, leptin and
inhibition of pancreatic lipase (Haque et al., 2014). Among
molecular mechanisms, Choi et al. (2017) assessed the role of
thymol (13) in 3T3-L1 white adipocytes via promoting
mitochondrial biogenesis, enhancing expression of a core set of
brown fat-specific markers as well as enhancing the protein levels of
PPARγ, PPARδ, pAMPK, pACC, HSL, PLIN, CPT1, ACO, PGC-
1α, and UCP1. It also augmented lipolysis, thermogenesis and fat
oxidation. In the case of carvacrol (12), it can act by reduction of
autophagy (essential for adipocyte maturation) and on
carbohydrate-responsive element-binding protein ChREBP
activity, reducing adipogenic differentiation (Spalletta et al., 2018).
The supplementation of this compound in the diet (0.1%) may
prevent diet-induced obesity by modulating gene expressions
involved and protein associated with the signaling cascades in
adipogenesis, as well as inflammation (Cho et al., 2012). Overall,
it seems that N. sativa has an interesting profile of phytochemicals,
which can act in different ways and require attention.
Neuroprotection
The role of N. sativa and its components as promising
neuropharmacological agents (Beheshti et al., 2016) in
facitilating learning and memory have been recently reviewed
(Sahak et al., 2016). In rats, 1 ml/kg of N. sativa oil for 14 days
depleted reactive oxygen species (ROS)/NO levels, improved
neurogenic proteins, acetylcholinesterase (AChE) activities and
neuro-cognitive markers depletions in chlopyrifos exposure
(Imam et al., 2018). Moreover, N. sativa oil improved
neurocognicives indices such as Morris water maze. In other
study performed in rats, the hydroalcoholic extracts of N. sativa
seeds (200 and 400 mg/kg, 5 days) were used to investigate its
effects on memory and brain tissues oxidative damage in
penthylenetetrazole-induced repeated seizures (Vafaee et al.,
2015). The results showed a beneficial effects of N. sativa on
learning and memory impairments (Morris water maze) and
improved antioxidant effects in the rat brain (lower MDA levels).
HEALTH-PROMOTING EFFECTS: CLINICAL
TRIALS IN HUMANS
Clinical studies have mostly confirmed some effects of the seeds
of N. sativa and their derivatives (seed extract and seed oil)
obtained in the aforementioned in vitro and in vivo animal
studies. Particularly, in the on line database about clinical
trials “www.clinicaltrials.gov”, there are 16 studies on N.
sativa. Among them, the status of four studies on blood lipids,
obesity and diabetes management has been completed, while
other two were about palmer arsenical keratosis and asthma. The
administration of N. sativa seeds (or seeds oil/extract) was alone
or with other herbal substances (e.g., Curcuma longa extract),
with different dosages and up to 60 days. Some of the results were
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TABLE 4 | Clinical trials on effect of Nigella sativa to various system disorders, diseases and conditions.
Intervention Application, duration Type of study Number of
patients/study
designa
Control Main effectsa References
Powdered N.
sativa seed
Oral application for 8






40 patients with HT
(aged between 22
and 50 years)
Placebo (starch) ↓ body weight and BMI, ↓
TSH and anti-TPO
antibodies, ↑ T3, ↓ serum
VEGF concentration
(Farhangi et al., 2016)
N. sativa
powder




40 patients with HT,
22–50 years
Placebo (starch) ↓ serum IL-23, ↓ TSH and
anti-TPO antibodies, ↑
serum T3, ↓ body weight
(Tajmiri et al., 2016)
N. sativa seed
powder
Oral application for 8





40 patients with HT
(aged between 22
and 50 years)
Placebo (starch) ↓ serum LDL and T3, ↑ HDL (Farhangi et al., 2018)
N. sativa
powdered seed
Oral application of 500 mg
in combination with













↓ FBG, PPBG, HbA1c, LDL (Najmi et al., 2012)
N. sativa
seed oil
Oral application for 3






70 patients with type
II diabetes
Mineral oil ↓ FBG, PPBG, HbA1c (Hosseini et al., 2013)
N. sativa seed
powder
Oral application of 2g
powder daily, for one year







type 2 diabetes on
standard oral
hypoglycemic drugs
Placebo (charcoal) ↓ FBG, HbA1c, TBARS ↑
TAC, SOD, GSH
(Kaatabi et al., 2015)
N. sativa oil soft
gel capsules
Oral application of 3g oil













Oral application of 2.5 mL







20–45 years of age
with infertility lasting
more than one year
Liquid paraffin Sperm count, motility,
morphology and semen






Two test groups received
100 and 200 mg of extract















Oral application of 2.5 mL








Mineral oil ↓ systolic and diastolic BPs (Fallah Huseini et al.,
2013)










pallor during the first





2 puffs/day of N. sativa
nasal spray (1 g/day of N.



















N. sativa oil Topical application, twice a










Ointment (1 G) topically
applied on eczematous
lesions twice a day for a









↓ Dermatology life quality
index score in Nigella and
betamethasone groups
compared to eucerin
(Yousefi et al., 2013)
(Continued on following page)
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positive, e.g. in total cholesterol and asthma, and subject of
publications (Qidwai et al., 2009; Koshak et al., 2017).
Furthermore, in the following section the results of other
clinical studies regarding preventive and relieving effects of N.
sativa on metabolic disorders and risk factors (diabetes, obesity
and hypertension), as well as other effects are shown. In Table 4,
we have summarized these effects. The effects of other Nigella
plants are also commented.
Effect of N. sativa Supplementation on
Patients with Metabolic Disorders and Risk
Factors
Metabolic Syndrome
The possibility of application of N. sativa seed in patients with
metabolic syndrome was firstly investigated by Najmi et al.
(2008). They found that the administration with N. sativa seed
oil (2.5 mL twice a day for 6 weeks) in patients with metabolic
syndrome significantly decreased FBG and LDL and increased
HDL levels. The same group of authors (Najmi et al., 2012)
analyzed the effect of supplementation with powdered N. sativa
seed (500 mg/day for two months) in patients with low
glycemic control (glycate hemoglobin—HbA1C was lower
than 7%). As a result, in the intervention group significant
lowering of FBG, postprandial blood glucose (PPBG) and
HbA1c was observed.
Conversely, a recent cross-over study (2 months treatment,
2 weeks washout period) evaluated the effects of N. sativa, as a
form of traditional bread spiked with seeds (2 g), on FBG, BP and
anthropometric indices (BW, waist circumference or WC, and
BMI body mass index) in patients with metabolic syndrome. It
found no significant effect between the mean of changes of
TABLE 4 | (Continued) Clinical trials on effect of Nigella sativa to various system disorders, diseases and conditions.
Intervention Application, duration Type of study Number of
patients/study
designa




12 weeks, group I: 10%w/
w ointment with N. sativa
oil extract; group II:
capsules with 500 mg of
N. sativa powder, three









- Group I—total healing of
psoriatic lesions, with good
response in 65% of
patients, and a relapse rate
of 31% four weeks after
cessation of treatment;
group II—good response in
50% of patients, with a
relapse rate of 50%
observed four weeks after
application; group III—total
cure of lesions, and good
responses in 85% of
patients, with a relapse rate
of 18%
(Jawad et al., 2014)
N. sativa oil Two placebo capsules
daily for 1 month, followed
by a month of NS oil








↓ disease activity score, ↓
number of swollen joints




N. sativa oil 500 mg oil capsules two








Placebo ↑ IL-10, ↓ MDA, ↓ NO (Hadi et al., 2016)
N. sativa oil Topical application twice a
day (in the morning and






Diclofenac gel Better pain relief effect
compared to diclofenac gel
according to KOOS score
(38.88 ± 17.84 and 50.33 ±
20.38, respectively)
(Azizi et al., 2019)
N. sativa seed Oral administration:
500 mg in capsules (twice
a day for 9 weeks)





of logical memory tests,
attention test (letter
cancenlation test and trail
making test), cognitive test
(Scroop)etc.
(Bin Sayeed et al.,
2013)
aBMI, body mass index; BP, blood pressure; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; HT, Hashimoto’s thyroiditis; IL, interleukin; LDL, low density lipoprotein; MDA,
malondialdehyde; PPBG, postprandial blood glucose; T3, total triiodothyronine; TAC, total antioxidant capacity; TBARS, thiobarbituric acid reactive substances; TG, triglycerides; TPO,
thyroid peroxidase; TSH, thyroid-stimulating hormone; VEGF, vascular endothelial growth factor.
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parameters in the beginning and end of study (time effect), with
the exception of diastolic BP (Mohtashami, 2019).
Diabetes
Oxidation and inflammation are important factors connected
with occurrence of various chronic diseases, such as diabetes
mellitus type 2 (Pouvreau et al., 2018). Due to the antioxidant,
antiobesity and antidiabetic effects of N. sativa seeds and their
constituents, this plant species can offer potential in prevention
and treatment of type 2 diabetes. A recent review suggests that N.
sativa can improve glycemic stages and lipid profile in diabetes
(Heshmati and Namazi, 2015).
Hosseini et al. (2013) investigated anti-hyperglycemic effect of
N. sativa seed oil in type II diabetic patients. As a result of
supplementation with 5 mL of oil/day for three months, blood
levels of fasting and 2 h PPBG, as well as HbA1c were significantly
decreased compared to placebo group. This hypoglycemic effect
can be result of an insulin senzitation and stimulation of
pancreatic beta-cell function, resulting in intensified activity
and consequent decrease in glucose level. Moreover, Kaatabi
et al. (2015) reported pronounced antidiabetic activity after
three-month application of N. sativa powdered seed (2 g/day)
in combination with oral hypoglycemic agent in patients with
type 2 diabetes. In this study, N. sativa received group showed
significant reduction of FBG, HbA1C, and TBARS, and at the
same time noticeable increase of the total antioxidant capacity,
SOD, and glutathione levels were recorded in the intervention
group. Heshmati et al. (2015) investigated effect of N. sativa seed
oil application (3 g/day) on glucose metabolism and lipid
concentrations in patients with type 2 diabetes. According to
this study, FBG, HbA1C, and levels of triglycerides (TG) and LDL
significantly changed in the intervention group compared to the
placebo one. On the other hand, insulin level and its resistance
decreased and HDL increased in the intervention group, but after
adjusting for confounder factors, these parameters were not
significant. Overall, the potential antidiabetic mechanisms of
N. sativa could be mediated through a change in the oxidative
status (either via upregulation of endogenous antioxidants or
reduction of oxidative species), reduction of inflammation, and
improvement of lipid profiles (Yimer et al., 2019). Furthermore, a
recent meta-analysis confirms that supplementation with N.
sativa could be a suitable choice to manage the complications
of type 2 diabetes, including FBS (−17.84 mg/dL), HbA1c
(−0.71%), total cholesterol (−22.99 mg/dL), and LDL
(−22.38 mg/dL) (Daryabeygi-Khotbehsara et al., 2017).
Hypercholesterolemia and Obesity
Nigella sativa powder supplementation (1 g/day) for sixty days
caused momentous reductions in concentrations of LDL, TG
levels and enhancement in HDL level in hypercholesterolemic
patients (Tasawar et al., 2011). Moreover, a double-blind,
randomized, placebo-controlled 4-weeks trial showed that the
administration of N. sativa seeds (1g/day) can reduce total
cholesterol and LDL. Thus, it can be interesting as lowering
lipid agent in hyperlipidaemic subjects (Pelegrin et al., 2019).
Nigella sativa oil (3 g/day for 8 weeks) was also tested in a low-
calorie diet on cardiometabolic risk factors in obese women.
Compared to the placebo group, in the N. sativa treated group,
weight (−6.0%) and WC (−6.9%) decreased. It also favored a
reduction in triglyceride and LDL levels (Mahdavi et al., 2015).
Recently, a recent meta-analysis (literature till June 2017) has
been performed on the effects of supplementation with N. sativa
on some anthropometric indices in adult subjects. It indicated
that N. sativa supplementation exerts a moderate effect on
reduction in BW (−2.11 kg), BMI (−1.16 kg/m2) and WC
(−3.52 cm) (Namazi et al., 2018). Nonetheless, other meta-
analysis performed till January 2018 suggested that N. sativa
supplementation have only an effect on BW (−1.76 kg) and BMI
(−0.85 kg/m2) in adults compared to placebo (Mousavi et al.,
2018).
Hypertension
There are several clinical studies reporting positive effect of N.
sativa application on hypertension. Dehkordi and Kamkhah
(2008) demonstrated that application of N. sativa seeds extract
(100 and 200 mg for eight weeks) in patients with mild
hypertension led to significant reduction of systolic and
diastolic BP compared to placebo. At the same time, a
significant decrease in total and LDL cholesterol was observed
and no other complications caused by the treatment were found.
Similar results were obtained for N. sativa seed oil. Fallah Huseini
et al. (2013) exhibited that its application in a dose 2.5 mL two
times per day for 8 weeks reduced systolic and dyastolic BP in
healthy volunteers. Authors suggested that the exhibited effect
could be attributed to the activity of thymoquinone (8), one of
main constituents of the volatile oil from N. sativa seed, as
commented before.
Some of the cardiovascular benefits evidenced in vitro and now
in vivo through risk factors, such as blood lipids, and BP, could be
related to the presence of omega-6 fats as linoleic acid, which is
the major fatty acid of the seed oil. Nonetheless, the
cardiovascular health benefits of linoleic acid are controversial
(Hooper et al., 2018; Marklund et al., 2019), and the positive
effects of minor phytochemicals remains unclear.
Other Effects of N. sativa
Effect of N. sativa Supplementation in Patients with
Hashimoto’s Thyroiditis (HT)
HT is one of the most common human autoimmune diseases
influencing the thyroid glands and an organ-specific T-cell
mediated disease (Chistiakov, 2005). The disease is ten times
more frequent in women than in men and it affects 2% of general
population. HT is associated with serious alterations in
composition and the transport of lipoproteins. Several clinical
studies have demonstrated the efficacy of N. sativa application in
patients with HT. According to the study conducted by Farhangi
et al. (2016), the application of powdered N. sativa seeds (2 g) for
eight weeks significantly decreased BW and BMI compared to
placebo. Also, a positive effect has been achieved on thyroid
function. A decrease in the serum concentrations of thyroid
stimulating hormone (TSH) and anti-thyroid peroxidase (anti-
TPO) has been shown, while serum concentrations of T3
increased in N. sativa treated group. In the same study,
significant reduction of vascular endothelial growth factor
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(VEGF) was noted in the intervention group. It has been observed
that its concentration grows during pathological states
characterized by increased TSH secretion (Farhangi et al., 2016).
These results were confirmed by Tajmiri et al. (2016) and
Farhangi et al. (2018), who showed lower BMIs in the group of
patients with HT after the treatment with N. sativa seeds. This
positive effect was exhibited through hypolipidemic effect:
lowering serum LDL cholesterol and TG concentrations, while
raising the level of HDL cholesterol. Beside this effect, Tajmiri
et al. (2016) showed that treatment withN. sativa seed powder for
eight weeks reduced levels of serum TSH, anti-TPO and IL-23,
while level of serum T3 was increased.
Effect of N. sativa Supplementation on Patients with
Reproductive System Disorders
Kolahdooz et al. (2014) studied effect of N. sativa seed oil on
abnormal semen quality in infertile man. These authors showed
that the daily application of 5 mL for two months significantly
improved sperm count, morphology and motility and volume of
semen, pH, and number of round cells. The exact mechanism of
the exhibited effect is not determined, but it is likely related to
strong antioxidant activity of the oil. Namely, it is well known that
high level of oxidative stress contributes to decreased semen
quality (Schulte et al., 2010).
Effect of N. sativa Supplementation on Patients with
Allergic Rhinitis
The potential of application of N. sativa seeds and its oil in
patients with allergic rhinitis has been also confirmed in clinical
studies. Nikakhlagh et al. (2011) showed in prospective and
double blind clinical trial that the oral administration of N.
sativa seed oil (6 mg/kg daily) for 30 days in patients with
allergic rhinitis significanly decreased the severity of
respiratory symptoms, such as the presence of the nasal
mucosal congestion, nasal itching, runny nose, sneezing
attacks, turbinate hypertrophy, and mucosal pallor. Moreover,
Rezaeian and Amoushahi Khouzani (2018) investigated the effect
ofN. sativa nasal spray in randomized clinical study. In this study
patients in the intervention group received 2 puffs/day of N.
sativa nasal spray (i.e. 1 g/day of N. sativa) and in the placebo
group received 2 puffs/day of sodium chloride spray (0.65%).
Lund–McKay, Lund Kennedy, and Sino-Nasal Outcome Test-22
scores were used and the outcomes were significantly lower in the
intervention group compared to the placebo group. These
findings are in line with previous reports about the
antihistamine properties of N. sativa (Boskabady and Sheiravi,
2002; Kanter et al., 2006).
Effect of N. sativa Supplementation on Patients with
Skin Diseases
Several clinical trials demonstrated positive effects of N. sativa
application in resolving symptoms related to some skin diseases.
Ghorbanibirgani et al. (2014) showed positive effects of 6 months
topical application of N. sativa oil on vitiligo lesions compared to
fish oil according to Vitiligo Area Scoring Index. In another study,
Yousefi et al. (2013) investigated the therapeutic potential of 2%
ointment topically applied (twice/day during 4 weeks) in patients
with hand eczema compared to eucerin and betamethasone.
According to scores obtained using Hand Eczema Severity
index and Dermatology Life Quality Index, they showed that
N. sativa ointment could have the same efficacy as
betamethasone, while it is more efficient compared to eucerin.
Jawad et al. (2014) investigated effect of various preparations of
N. sativa in psoriasis treatment. A first group has been receiving
Nigella ointment topically (10% w/w, twice daily), the second
group took crude pulverized plant (capsules with 500 mg three
times daily), while the third group received the combination of
both treatments. The inspected reaction has been estimated
following the Psoriasis Area and Severity Index score, while
MDA serum level was used as indicator of the oxidative stress.
After 12 weeks of treatment ointment reached total healing of
psoriatic lesions, with good response in 65% of patients, and a
relapse rate of 31% four weeks after cessation of treatment. Oral
doses of N. sativa developed good response in 50% of patients,
with a relapse rate of 50% observed four weeks after application.
The combination of ointment and oral doses gained best
results—total cure of lesions, and good responses in 85% of
patients, with a relapse rate of 18%. All of these positive
effects of N. sativa in dermatological diseases could be
attributed to its antimicrobial, antioxidant,
immunomodulatory, and anti-inflammatory effects.
Effect of Nigella sativa Supplementation in Patients
with Rheumatic Artritis
The efficacy of black cumin oil in patients with rheumatoid
arthritis (RA) was evaluated in female patients diagnosed with
RA. Application of N. sativa oil in capsules (500 mg) twice daily
exhibited improvement in disease activity score compared to
placebo. Respectively, a pronounced improvement was
demonstrated in amount of inflamed joints and occurrence
of morning stiffness (Gheita and Kenawy, 2012). These
results were confirmed by Hadi et al. (2016) with higher
doses of N. sativa oil (1 g of oil/day, divided in two
capsules). They showed that after 8 weeks of application in
patients with RA noticeable decrease of serum MDA and NO
was observed in the intervention group, while at the same time
the serum level of anti-inflammatory cytokine IL-10 was
increased (Hadi et al., 2016).
Azizi et al. (2019) compared the effects of topical application
of N. sativa oil and diclofenac gel in patients with osteoartritis,
one of the most common diseases in aging population. In this
study, pain score has been expressed as average number
obtained using Knee injury and Osteoarthritis Outcome
Score scale. It has been observed that first ten days there has
been no significant differences in placebo and the intervention
group. Still, after 21 days of application better pain relief effect
was observed after treatment with N. sativa oil compared to
diclofenac gel.
Effects on Memory, Attention and Cognition
In a randomized study with 20 healthy humans, the effects of
500 mg of N. sativa seeds (twice a day for 9 weeks) on memory,
attention, and cognition were studied. The results showed an
improvement in the score of the tests studied, without an
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alteration of the biochemical markers of cardiac, liver and kidney
functions (Bin Sayeed et al., 2013).
Effects of Other Nigella Species
Among other herbs, there are several studies on the clinical use of
N. ciliaris during childbirth and postpartum (Ali-Shtayeh et al.,
2015), against diabetes (Ali-Shtayeh et al., 2012) and
hypertension (Ali-Shtayeh et al., 2013), as well as N. arvensis
against psoriasis (Jaradat et al., 2016b) and cancer (Jaradat et al.,
2016a), which were performed in Palestine using questionnaires.
Some patients seem to be satisfied with the outcomes of herbal
therapy (Ali-Shtayeh et al., 2012; Ali-Shtayeh et al., 2013), but the
authors did not reveal the herb treatment that was successful to
manage the latter diseases/conditions. In any case, clinical
evidences are still lacking and no studies have been found in
the abovementioned database https://clinicaltrials.gov/.
CONCLUSION
Nigella seeds and extracts have a wide range of bioactivities,
which have been demonstrated in vitro and in vivo. Nonetheless,
N. sativa is the most studied species probably due to their
popularity in folklore medicine. In all cases, future
perspectives should be oriented to perform a better
characterization of the constituents of the extracts since most
studies were only focused on determining the concentration of
thymoquinone, but other phytochemicals could be present as in
this review more than 80 compounds have been reported. This is
also important to remark that bioavailability could affect the way
that Nigella components act in vivo, e.g., some studies
administered Nigella products orally, while other intravenously.
When referring to clinical trials, it seems that the
supplementation of N. sativa can exert some effects on
diabetes, obesity, and hypertension, among others.
Nonetheless, the administration way (seeds, powder, oil, etc.),
the dose and the treatment period are highly variable and should
be further established from a therapeutic point of view, as well the
chemical and phytochemical composition. This should be further
study in order to formulate functional ingredients/nutraceuticals
to promote the health benefit and how should be added into food.
Moreover, besides the pleiotropic health applications of Nigella, it
can be useful in nanotechnology applications as well as to
modulate the activity of other therapeutic agents.
It is important to highlight that the culinary and medicinal use
of some Nigella seeds as spice, condiment or infusion (e.g., N.
sativa, N. damascena, and N. arvensis) suggests that their
consumption is safe. The seeds are characterized by a low
toxicity degree (Ali and Blunden, 2003) and no serious side
effects in clinical trials (Namazi et al., 2018), but more studies
were focused on N. sativa. In fact, toxicity studies performed in
animal models also suggest a wide of margin of safety for usingN.
sativa fixed oil, with high LD50 value (28.8 ml of oil/kg BW
administered orally to mice) (Zaoui et al., 2002), in powder form
(Dollah et al., 2013) and as extracts (Vahdati-Mashhadian et al.,
2005).
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